{"DataElement":{"publicId":"7359832","version":"1","preferredName":"Aplastic Anemia Classification Type","preferredDefinition":"A description of the aplastic anemia classification.","longName":"2911995v1.0:7359828v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2911995","version":"1","preferredName":"Aplastic Anemia Classification","preferredDefinition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow).  The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well.  Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors. -- 2004 _A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"2934401v1.0:2321361v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2934401","version":"1","preferredName":"Aplastic Anemia","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells.","longName":"C2870","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"71804AB9-DDB7-D0CF-E040-BB89AD436831","latestVersionIndicator":"Yes","beginDate":"2009-08-19","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-08-19","modifiedBy":"ONEDATA","dateModified":"2009-08-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2321361","version":"1","preferredName":"Classification","preferredDefinition":"Classification; the grouping of things into classes or categories.","longName":"C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FCF89106-20AF-2D93-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-29","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-07-29","modifiedBy":"ONEDATA","dateModified":"2005-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6D825F54-3B51-678C-E040-BB89AD431C7F","latestVersionIndicator":"Yes","beginDate":"2009-06-29","endDate":null,"createdBy":"ZHANGW","dateCreated":"2009-06-29","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7359828","version":"1","preferredName":"Aplastic Anemia Type","preferredDefinition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors._Something distinguishable as an identifiable class based on common qualities.","longName":"7359828v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Acquired AA secondary to immunotherapy or immune effector cell therapy","valueDescription":"Secondary To Immunotherapy Or Effector Immune Cell Therapeutic Procedure Aplastic Anemia","ValueMeaning":{"publicId":"7359829","version":"1","preferredName":"Secondary To Immunotherapy Or Effector Immune Cell Therapeutic Procedure Aplastic Anemia","longName":"7359829","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.: Used as a function word to indicate direction, purpose, or movement.: Therapy designed to induce changes in a patient's immune status in order to treat disease.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: An immune cell, usually a T- or B- lymphocyte, that is responding to an antigen exposure.: An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.: A condition in which the bone marrow is unable to produce blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"6"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"Immunotherapy","conceptCode":"C15262","definition":"Therapy designed to induce changes in a patient's immune status in order to treat disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Effector Immune Cell","conceptCode":"C28241","definition":"An immune cell, usually a T- or B- lymphocyte, that is responding to an antigen exposure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE24F61-F9A8-2C57-E053-4EBD850A58FA","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AAE24F61-F9C1-2C57-E053-4EBD850A58FA","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Acquried AA secondary to chemotherapy","valueDescription":"Secondary To Chemotherapy Aplastic Anemia","ValueMeaning":{"publicId":"7359830","version":"1","preferredName":"Secondary To Chemotherapy Aplastic Anemia","longName":"7359830","preferredDefinition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.: Used as a function word to indicate direction, purpose, or movement.: The use of synthetic or naturally-occurring chemicals for the treatment of diseases.: A condition in which the bone marrow is unable to produce blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary","conceptCode":"C25667","definition":"Derived as a result of a primary condition; not direct or immediate; of second rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"To","conceptCode":"C65107","definition":"Used as a function word to indicate direction, purpose, or movement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE24F61-F9D0-2C57-E053-4EBD850A58FA","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AAE24F61-F9E9-2C57-E053-4EBD850A58FA","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Acquired amegakaryocytosis (not congenital)","valueDescription":"Not Genetic Amegakaryocytosis","ValueMeaning":{"publicId":"2689232","version":"1","preferredName":"Not Genetic Amegakaryocytosis","longName":"2689232v1.00","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction._Having to do with information that is passed from parents to offspring through genes in sperm and egg cells._A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Genetic","conceptCode":"C17938","definition":"Having to do with information that is passed from parents to offspring through genes in sperm and egg cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Amegakaryocytosis","conceptCode":"C61248","definition":"A non-neoplastic, congenital or non-congenital disorder charcaterized by marked reduction or absence of megakaryocytes and thrombocytopenia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3C4CD380-7E91-58CC-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-10-12","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-10-12","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AAE24F61-F9F3-2C57-E053-4EBD850A58FA","beginDate":"2007-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Acquired AA, secondary to hepatitis","valueDescription":"Aplastic Anemia due to Hepatitis","ValueMeaning":{"publicId":"2593261","version":"1","preferredName":"Aplastic Anemia due to Hepatitis","longName":"2593261","preferredDefinition":"Bone marrow failure defined as pancytopenia, secondary to hepatitis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia due to Hepatitis","conceptCode":"C61231","definition":"Bone marrow failure defined as pancytopenia, secondary to hepatitis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CB39-0225-077C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"KUMMEROA","dateModified":"2020-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AAE24F61-FA1B-2C57-E053-4EBD850A58FA","beginDate":"2007-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Acquired AA, secondary to toxin / other drug","valueDescription":"Drug-Induced Aplastic Anemia","ValueMeaning":{"publicId":"2593263","version":"1","preferredName":"Drug-Induced Aplastic Anemia","longName":"2593263","preferredDefinition":"A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug-Induced Aplastic Anemia","conceptCode":"C35343","definition":"A state of bone marrow suppression and failure that is caused by a cytotoxic or adverse immunologic response to a drug treatment, leading to a failure of production of red blood cells, white cells and platelets.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2880CBB6-2204-0782-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-02","modifiedBy":"KUMMEROA","dateModified":"2020-10-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AAE24F61-FA2F-2C57-E053-4EBD850A58FA","beginDate":"2007-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Acquired pure red cell aplasia (not congenital)","valueDescription":"Acquired Pure Red Cell Aplasia","ValueMeaning":{"publicId":"3322381","version":"1","preferredName":"Acquired Pure Red Cell Aplasia","longName":"3322381","preferredDefinition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children.  Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Pure Red Cell Aplasia","conceptCode":"C70548","definition":"A disease characterized by normocytic, normochromic anemia, low hematocrit, reticulocytopenia and selective erythroid hypoplasia. It can occur as a chronic or acute form; the former is predominantly seen in adults and the latter in children. Pathogenesis involves immune dysfunction with antibodies directed against erythroid precursor cells or erythropoietin, or due to T-cell mediated suppression of erythropoiesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B36DFA8A-BB14-6AE7-E040-BB89AD432073","latestVersionIndicator":"Yes","beginDate":"2011-12-06","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-12-06","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AADFA6AB-9DF0-2385-E053-4EBD850A59E1","beginDate":"2007-10-12","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"ONEDATA","dateModified":"2020-07-20","deletedIndicator":"No"},{"value":"Other acquired cytopenic syndrome","valueDescription":"Other Acquired Cytopenia","ValueMeaning":{"publicId":"3923943","version":"1","preferredName":"Other Acquired Cytopenia","longName":"3923943","preferredDefinition":"Different than the one(s) previously specified or mentioned.: Of or relating to a medical condition or characteristic that is not present at birth and develops subsequently.: A reduction in the number of blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytopenia","conceptCode":"C2979","definition":"A laboratory test result indicating an abnormally low quantity of circulating blood cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E907184B-662C-D39A-E040-BB89AD431AF5","latestVersionIndicator":"Yes","beginDate":"2013-10-18","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2013-10-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B9A5CE-19BE-5B57-E053-4EBD850A60C1","beginDate":"2020-10-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"},{"value":"Acquired AA, not otherwise specified","valueDescription":"Not Otherwise Specified Acquired Aplastic Anemia","ValueMeaning":{"publicId":"7465963","version":"1","preferredName":"Not Otherwise Specified Acquired Aplastic Anemia","longName":"7465963","preferredDefinition":"Not characterized in any other way.: Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.: A condition in which the bone marrow is unable to produce blood cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Acquired","conceptCode":"C85869","definition":"Of or relating to a medical condition or characteristic that is not present at birth but develops subsequently.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1B9A5CE-19CC-5B57-E053-4EBD850A60C1","latestVersionIndicator":"Yes","beginDate":"2020-10-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B1B9A5CE-19E5-5B57-E053-4EBD850A60C1","beginDate":"2020-10-15","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-15","modifiedBy":"ONEDATA","dateModified":"2020-10-15","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2486852","version":"1","preferredName":"Aplastic Anemia Type","preferredDefinition":"A condition in which the bone marrow is unable to produce blood cells.:Type; a subdivision of a particular kind of thing.","longName":"C2870:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aplastic Anemia","conceptCode":"C2870","definition":"Anemia resulting from bone marrow failure (aplastic or hypoplastic bone marrow). The production of erythroblasts and red cells is markedly decreased, and it may be associated with decreased production of granulocytes (granulocytopenia) and platelets (thrombocytopenia) as well. Aplastic anemia may be idiopathic or secondary due to bone marrow damage by toxins, radiation, or immunologic factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"16483FEE-1DFA-20B8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-06-15","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-06-15","modifiedBy":"ONEDATA","dateModified":"2006-06-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE24F61-F98A-2C57-E053-4EBD850A58FA","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"12/03/2020 KMM; 2020-10-19 ak Added 2 defs to existing PVs for KM.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_AA_aa_class_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the classification o","type":"Preferred Question Text","description":"What was the classification of the aplastic anemia?","url":null,"context":"NHLBI"},{"name":"Specify the aplastic anemia classification","type":"Application Standard Question Text","description":"Specify the aplastic anemia classification","url":null,"context":"NHLBI"},{"name":"Specify the aplastic anemia classification","type":"Alternate Question Text","description":"Specify the aplastic anemia classification","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAE268D5-963E-2C4D-E053-4EBD850A73F4","latestVersionIndicator":"Yes","beginDate":"2020-07-20","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-07-20","modifiedBy":"MALUMK","dateModified":"2020-12-03","changeDescription":"Released. 12/03/2020 KMM; System generated def displayed as alt def. 07/20/2020 KMM. ALT name added. 11/13/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}